Search Results

Baxter Reports Fourth-Quarter and Full-Year 2023 Results

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2023, and provided its financial guidance for full-year and first-quarter 2024. 

Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2023 financial results on Thursday, February 8, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://conferencingportals.com/event/etCeELhb to pre-register for the call and receive the call information.

Baxter Advances First Intravenous (IV) Bag Recycling Pilot for U.S. Hospitals

Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, announced the completion of the first phase of its intravenous (IV) bag recycling program pilot.

Baxter to Present at 42nd Annual J.P. Morgan Healthcare Conference

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024. José (Joe) E. Almeida, Baxter's chairman, president and chief executive officer, is scheduled to present at 10:30 a.m. Pacific Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Friday, July 5, 2024.

Baxter Publishes Task Force on Climate-related Financial Disclosures (TCFD) Report and is Named to Dow Jones Sustainability Index North America

Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its first report aligned with the Task Force on Climate-related Financial Disclosures (TCFD) recommendations, which were recently incorporated into the International Sustainability Standards Board Standards.

Lifelong Advocate for People with Disabilities

Baxter's enABLES business resource group fosters inclusion and belonging for employees, caregivers and advocates of those with visible and nonvisible disabilities, while helping Baxter better represent the diverse needs of the patients and the caregivers we serve. In honor of December 3 as the International Day of Persons with Disabilities, we chatted with enABLES co-president Zach Wiles, who shared his thoughts on disability inclusion at Baxter.

Called to Serve His Fellow Vets

Baxter's BaxVET business resource group offers volunteer and networking opportunities benefiting service members and military families while supporting veterans making the transition from the military to Baxter. To learn more, we sat down with Robert Lipp, retired Chief Petty Officer, United States Navy, and co-chair of our BaxVET chapter in Skaneateles Falls, New York.

Baxter Issues Urgent Medical Device Correction for Novum IQ Syringe Infusion Pump Due to Potential Impact of Downstream Occlusions on Infusion Volume

Baxter International Inc. announced today it has issued an Urgent Medical Device Correction for the Novum IQ syringe infusion pump. The Correction is due to the potential for an incomplete infusion following one or more downstream occlusion alarms. Baxter notified impacted customers in October and is developing a software upgrade to resolve the issue. There have been no reports of serious injury associated with this issue to date.

The Baxter International Foundation and UNICEF Partner to Expand Access to Safe Water and Sanitation in Egypt

The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), and UNICEF, today announced a partnership to improve access to safe drinking water and sanitation in five water-challenged regions in Egypt.

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on January 2, 2024, to shareholders of record as of December 1, 2023. The indicated annual dividend rate is $1.16 per share of common stock. About Baxter